These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15254199)

  • 1. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.
    Lee E; Hall RA; Lobigs M
    J Virol; 2004 Aug; 78(15):8271-80. PubMed ID: 15254199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.
    Lee E; Lobigs M
    J Virol; 2002 May; 76(10):4901-11. PubMed ID: 11967307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
    J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: generation of attenuated strains of the virus.
    Chiou SS; Chen WJ
    Vaccine; 2007 Dec; 26(1):15-23. PubMed ID: 18045754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants.
    Ni H; Barrett AD
    Virology; 1998 Feb; 241(1):30-6. PubMed ID: 9454714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitness of Japanese encephalitis virus to Neuro-2a cells is determined by interactions of the viral envelope protein with highly sulfated glycosaminoglycans on the cell surface.
    Chiou SS; Liu H; Chuang CK; Lin CC; Chen WJ
    J Med Virol; 2005 Aug; 76(4):583-92. PubMed ID: 15977230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. West Nile virus is neutralized by HOCl-modified human serum albumin that binds to domain III of the viral envelope protein E.
    Vossmann M; Kirst M; Ludolfs D; Schreiber M
    Virology; 2008 Apr; 373(2):322-8. PubMed ID: 18191981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.
    Lee E; Weir RC; Dalgarno L
    Virology; 1997 Jun; 232(2):281-90. PubMed ID: 9191841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination.
    Lee E; Wright PJ; Davidson A; Lobigs M
    J Gen Virol; 2006 Oct; 87(Pt 10):2791-2801. PubMed ID: 16963737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GAG-binding variants of tick-borne encephalitis virus.
    Kozlovskaya LI; Osolodkin DI; Shevtsova AS; Romanova LIu; Rogova YV; Dzhivanian TI; Lyapustin VN; Pivanova GP; Gmyl AP; Palyulin VA; Karganova GG
    Virology; 2010 Mar; 398(2):262-72. PubMed ID: 20064650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic differences of E gene of a Thai strain of Japanese encephalitis virus that determine small plaque size phenotype but not neurovirulence in suckling mice.
    Lorroengsil S; Chen A; Sällberg M; Pantuwatana S
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):387-93. PubMed ID: 18564676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus.
    Maier CC; Delagrave S; Zhang ZX; Brown N; Monath TP; Pugachev KV; Guirakhoo F
    Virology; 2007 Jun; 362(2):468-74. PubMed ID: 17303204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison and discrimination of the biological characteristics between West Nile virus and Japanese encephalitis virus].
    Zhang JS; Zhang PH; Si BY; Yang H; Cao WC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):340-3. PubMed ID: 16415991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells?
    Ren J; Ding T; Zhang W; Song J; Ma W
    Virol J; 2007 Sep; 4():83. PubMed ID: 17803826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of West Nile virus and Japanese encephalitis virus using real-time PCR with a probe common to both viruses.
    Shirato K; Miyoshi H; Kariwa H; Takashima I
    J Virol Methods; 2005 Jun; 126(1-2):119-25. PubMed ID: 15847927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro.
    Chen LK; Lin YL; Liao CL; Lin CG; Huang YL; Yeh CT; Lai SC; Jan JT; Chin C
    Virology; 1996 Sep; 223(1):79-88. PubMed ID: 8806542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2.
    Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF
    J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.
    Wicker JA; Whiteman MC; Beasley DW; Davis CT; Zhang S; Schneider BS; Higgs S; Kinney RM; Barrett AD
    Virology; 2006 Jun; 349(2):245-53. PubMed ID: 16624366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.